Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Continentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 µg/mL against S. aureus, including the Methicillin-resistant Staphylococcus aureus (MRSA) and Methicillin susceptible Staphylococcus aureus (MSSA) and standard strains.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 100.00 |
Description | Continentalic acid from Aralia continentalis has minimum inhibitory concentrations (MICs) of approximately 8-16 µg/mL against S. aureus, including the Methicillin-resistant Staphylococcus aureus (MRSA) and Methicillin susceptible Staphylococcus aureus (MSSA) and standard strains. |
In vitro | Percentage of growth inhibition was evaluated by sulphorhodamine B assay. Purified Continentalic acid showed moderate cytotoxicity against all the cell lines used. In contrast, the extract exhibited significant concentration dependant cytotoxicity against A-549 (lung), THP-1 (leukemia) and MCF-7 (breast) cell lines[1] |
Source |
Molecular Weight | 302.45 |
Formula | C20H30O2 |
CAS No. | 19889-23-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Continentalic acid 19889-23-7 GPCR/G Protein Immunology/Inflammation Microbiology/Virology Neuroscience NOS Antibacterial Prostaglandin Receptor COX Bacterial inhibit Inhibitor inhibitor